Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

PAF antagonist demonstrates antipruritic activity in patients with atopic dermatitis

Dec. 18, 1997

First U.S. trials of Zemaphyte to begin

Dec. 17, 1997

Once-daily tacalcitol vs. twice-daily calcipotriol for chronic plaque psoriasis

Dec. 17, 1997

Bard to distribute ProCyte's wound care products

Dec. 17, 1997

Gliatech's ADCON-L recommended for approval

Dec. 15, 1997

Propecia recommended for approval for hair loss in men

Dec. 9, 1997

Preclinical profile of Novartis' dermatology candidate

Dec. 9, 1997

Promising results reported from pilot trial of Repel

Dec. 9, 1997

New melanogenesis inhibitor isolated from actinomycete

Dec. 1, 1997

Novel retinoids from Roche

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...